Synthesis and Evaluation of the Antidiabetic Potentials of Chitosan Combinations with Metformin and Momordica Balsamina Leaf Extract in Alloxan-Induced Diabetic Rats
Author(s) -
Nafisatu Kabir,
Aliyu Sunusi Aliyu,
Jibrin Iliyasu Jibrin
Publication year - 2022
Publication title -
dutse journal of pure and applied sciences
Language(s) - English
Resource type - Journals
eISSN - 2635-3490
pISSN - 2476-8316
DOI - 10.4314/dujopas.v7i3a.11
Subject(s) - chitosan , metformin , alloxan , chitin , chemistry , glipizide , diabetes mellitus , pharmacology , insulin , carbohydrate metabolism , medicine , biochemistry , endocrinology
Chitosan, a carbohydrate biopolymer, is medically gaining attention as a dietary supplement and a drug beneficial for improving blood glycemia, impaired glucose tolerance and altered lipid metabolism. Largely obtained from crustaceans, chitosan is also a promising vehicle used to deliver anti-diabetic drugs in implantable as well as injectable and oral routes. The present study is therefore aimed to synthesize chitosan and evaluate its antidiabetic potentials in combination with metformin and/or methanolic leaf extract of Momordica balsamina (MBM) in alloxan-induced diabetic rats. Chitosan was synthesized from crayfish shell through demineralization, deproteinization, deacetylation, and decolouration of the produced chitin. In the present study, a simple and an inexpensive acid-base titrimetric method was used for the determination of degree of deacetylation while the physicochemical properties; moisture content and ash content were determined using standard procedures.The efficacy of the drug binary systems of chitosan-metformin and chitosan-MBM were evaluated on the glucose tolerance of Wistar Albino rats made diabetic by a single interperitoneal injection of alloxan monohydrate (150 mg/kg body weight). The oral administration of both drug binary systems and chitosan exerted a significant (p<0.05) improvement on carbohydrate metabolism via glucose tolerance test when compared to the untreated diabetic rats. The blood glucose level of the chitosan group returned to near normal level 2 hours post-porandially, while chitosan-MBM, chitosanmetformin and metformin groups returned to their initial values only after 4 hours. Our findings are suggestive of the fact that chitosan-based drug binary systems possess anti-hyperglycemic activities and thus the potential to improve the pharmacokinetic and pharmacological profile of oral hypoglycemic drugs/herbs. Our findings could serve as basis for the development of novel antidiabetic drug systems.
Keywords: Antidiabetic, Chitosan, Metformin, Methanolic extract, Momordica balsamina
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom